FIELD: chemistry.
SUBSTANCE: invention discovers derivatives of 5β-sapogenin and pseudo sapogenin of general formula or , where in general formula I or II: R1 R2, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13 and R15 if available-H, independently R1 and R13-OH or R3-OH, =O or OR, where R - optionally substituted alkyl; lower acyl optinally substituted with carbamonyl or amino or lower alkoxycarbamonyl; lower alkoxycarbamonyl; R14 lower alkyl, optionally double bond with the exception of smylagenin and those compounds of formula I where simultaneously R1= R2= R4= R5= R6= R7= R8=R9= R10= R11= R12= R13=H, R3=β OH, R14=CH3, and methyl in C20 condition has α-orientation and C25 has S-configuration.
EFFECT: compounds increases muscarine receptor number and are useful for enhancement of human or animal cognitive function.
12 cl, 17 ex, 5 dwg, 21 tbl
Title | Year | Author | Number |
---|---|---|---|
STEROID SAPOGENINS AND THEIR DERIVATIVES USABLE IN MEDICAL TREATMENT | 2004 |
|
RU2297228C2 |
DERIVATIVES OF SAPOGENIN, THEIR SYNTHESIS, USING AND METHOD BASED ON THEIR USING | 2002 |
|
RU2311423C2 |
STEROID SAPOGENIN AND THEIR DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE | 1999 |
|
RU2242978C2 |
THERAPEUTIC METHODS AND APPLICATIONS OF SAPOGENINS AND DERIVATIVES THEREOF | 2003 |
|
RU2332999C2 |
METHOD OF STEREO-SPECIFIC REDUCTION OF SAPOGENINE-3 | 2003 |
|
RU2326890C2 |
COMPOSITIONS FOR TREATMENT OF NEURODEGERATIVE DISEASES | 2018 |
|
RU2792562C2 |
ORGANIC COMPOUNDS | 2012 |
|
RU2610094C2 |
ISOINDOLINE COMPOSITIONS AND METHODS OF TREATING NEURODEGENERATIVE DISEASE | 2015 |
|
RU2692258C2 |
PHARMACEUTICAL COMPOSITION FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASE | 2012 |
|
RU2618412C2 |
COMPOSITION FOR TREATING OR PREVENTING NEURODEGENERATIVE DISORDERS | 2012 |
|
RU2699038C2 |
Authors
Dates
2008-05-27—Published
2000-09-29—Filed